Skip to main content
Equibles
CRVS logo

CRVS · Corvus Pharmaceuticals, Inc. · Executive Compensation

Track CRVS — free

Use CRVS with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research CRVS.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$12.91 -0.03 (-0.23%) At close · Sep 11
Russell 2000 member Rebalance outlook locked
Market Cap
$1.09B
Shares
84.12M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

No Compensation Data

No Summary Compensation Table has been imported from this company's proxy statements yet.

Executive changes

Person Change Filed
Ian T. Clark Resigned 2026-07-22
Scott Morrison Resigned 2026-04-23
Andrew C. Chan, M.D., Ph.D. Appointed 2026-04-23
David Moore Appointed 2025-10-02
Richard van den Broek Appointed 2025-04-09
Key facts CIK 1626971 CUSIP 221015100 13F (30d) 61 filings 61 filers Visit website Investor relations